In this study, our data confirmed that Givinostat, a Class I and II HDAC inhibitor, is a potent inhibitor for cellular proliferation and strong inducer for apoptosis in Imatinib-resistant Ph+ B-cell lymphoblastic leukemia cells, SUP-B15. Here, HDAC9 is linked to precursor B-cell acute lymphoblastic leukemia.